SCHEMBL29254459

SCHEMBL29254459

COc1ccc(-c2n[nH]c3c2cnc2ccccc23)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 3/20 0.59
▸ PDE4B Q07343 3/20 0.59
▸ PDE4C Q08493 3/20 0.59
▸ PDE4D Q08499 3/20 0.59
▸ PIK3CD O00329 1/20 0.51
▸ PIK3CA P42336 1/20 0.51
▸ PIK3CB P42338 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ PIK3CG P48736 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ADORA1 P30542 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ GUSB P08236 1/20 0.46
▸ ACACA Q13085 1/20 0.46
▸ PDPK1 O15530 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ PDGFRB P09619 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30951527 1.00 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL29254456 0.85 DYRK1A (0.47) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL30951531 0.85 DYRK1A (0.47) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL30951512 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL29254461 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL29254513 0.77 ALDH1A1 (0.50) KDM4ENPC1ALDH1A1HPGDMAPT
SCHEMBL6477699 0.74 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DADORA1
SCHEMBL5246987 0.72 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DL3MBTL1
SCHEMBL11683985 0.71 PDE4A (0.62) PDE4APDE4BPDE4CPDE4DPIK3CD
SCHEMBL7669074 0.70 ACACA (0.59) L3MBTL1KDM4ENPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US claimed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN claimed
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 — — US disclosed
CN-118076605-A Substituted 1H-pyrazolo [4,3-c ] quinolines, methods of preparation and uses thereof 洛蒙治疗公司 2024-05-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF FLT3, PDXK, PHKG1 PDE4A 1567/4885PDE4B 1997/4885PDE4C 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback